Decitabine

CAS 2353-33-5 17 current records 4 historicalSmall Molecule

Who holds supplier records for Decitabine? 17 organisations hold a current record for Decitabine: an active US FDA Type II Drug Master File. A further 4 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (8), China (3), Taiwan (1), Spain (1) and 2 other countries (2); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Decitabine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/decitabine

Reading the evidence

  • 17 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (17)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Decitabine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Decitabine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (4)

Organisations whose Type II DMFs for Decitabine are no longer active. These show a past filing, not current supply.

Show all 4 historical records

Overview

Decitabine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201129).

Chemical identity

IUPAC name
4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one
Canonical SMILES
C1[C@@H]([C@H](O[C@H]1N2C=NC(=NC2=O)N)CO)O
InChIKey
XAUDJQYHKZQPEU-KVQBGUIXSA-N
Synonyms
2'-deoxy-5-azacytidine, DAC, Dacogen, Decitabina, Decitabine, Decitabine component of astx-727, Decitabine component of astx727, Decitabine component of inqovi, NSC-127716, 5-Aza-2'-deoxycytidine, 5-Azadeoxycytidine, 5-Aza-deoxycytidine

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Nucleoside Metabolic Inhibitor
Mechanism of action
Nucleic Acid Synthesis Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Decitabine?

17 organisations hold an active US FDA Type II Drug Master File or a CEP for Decitabine: SCINOPHARM TAIWAN LTD (Taiwan), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), CQ INTERNATIONAL CO INC, Dr. Reddy's Laboratories Ltd. (India), Emcure Pharmaceuticals Limited (India), FARMHISPANIA SA (Spain), Intas Pharmaceuticals Ltd. (India) and ITF CHEMICAL LTDA (Brazil), and 9 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Decitabine Drug Master Files are active?

SCINOPHARM TAIWAN LTD (DMF 23387, 27543), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 29697), CQ INTERNATIONAL CO INC (DMF 25988), Dr. Reddy's Laboratories Ltd. (DMF 23596), Emcure Pharmaceuticals Limited (DMF 26948), FARMHISPANIA SA (DMF 34163), Intas Pharmaceuticals Ltd. (DMF 25317) and ITF CHEMICAL LTDA (DMF 26708) and 9 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Decitabine records mean?

4 organisations have only inactive Type II DMFs for Decitabine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Decitabine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Decitabine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.